Tobacco addiction and the dysregulation of brain stress systems

被引:117
作者
Bruijnzeel, Adrie W. [1 ]
机构
[1] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA
关键词
Tobacco; Nicotine; Addiction; Dependence; Depression; Anxiety; CRF; NPY; Hypocretin; Norepinephrine; CORTICOTROPIN-RELEASING-FACTOR; PRECIPITATED NICOTINE WITHDRAWAL; PITUITARY-ADRENAL AXIS; NEUROPEPTIDE-Y NPY; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; OLFACTORY BULBECTOMIZED RAT; BUNGAROTOXIN BINDING-SITES; RECEPTOR PARTIAL AGONIST; SOCIAL-INTERACTION TEST; CENTRAL-NERVOUS-SYSTEM;
D O I
10.1016/j.neubiorev.2012.02.015
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Tobacco is a highly addictive drug and is one of the most widely abused drugs in the world. The first part of this review explores the role of stressors and stress-associated psychiatric disorders in the initiation of smoking, the maintenance of smoking, and relapse after a period of abstinence. The reviewed studies indicate that stressors facilitate the initiation of smoking, decrease the motivation to quit, and increase the risk for relapse. Furthermore, people with depression or an anxiety disorder are more likely to smoke than people without these disorders. The second part of this review describes animal studies that investigated the role of brain stress systems in nicotine addiction. These studies indicate that corticotropin-releasing factor, Neuropeptide Y, the hypocretins, and norepinephrine play a pivotal role in nicotine addiction. In conclusion, the reviewed studies indicate that smoking briefly decreases subjective stress levels but also leads to a further dysregulation of brain stress systems. Drugs that decrease the activity of brain stress systems may diminish nicotine withdrawal and improve smoking cessation rates. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1418 / 1441
页数:24
相关论文
共 389 条
  • [1] Violent assault, posttraumatic stress disorder, and depression - Risk factors for cigarette use among adult women
    Acierno, R
    Kilpatrick, DG
    Resnick, HS
    Saunders, BE
    Best, CL
    [J]. BEHAVIOR MODIFICATION, 1996, 20 (04) : 363 - 384
  • [2] NEUROPEPTIDE-Y DISTRIBUTION IN HUMAN-BRAIN
    ADRIAN, TE
    ALLEN, JM
    BLOOM, SR
    GHATEI, MA
    ROSSOR, MN
    ROBERTS, GW
    CROW, TJ
    TATEMOTO, K
    POLAK, JM
    [J]. NATURE, 1983, 306 (5943) : 584 - 586
  • [3] NICOTINE AND SMOKING - EFFECTS UPON SUBJECTIVE CHANGES IN MOOD
    AGUE, C
    [J]. PSYCHOPHARMACOLOGIA, 1973, 30 (04): : 323 - 328
  • [4] Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse
    al'Absi, M
    Hatsukami, D
    Davis, GL
    [J]. PSYCHOPHARMACOLOGY, 2005, 181 (01) : 107 - 117
  • [5] Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse
    al'Absi, M
    Hatsukami, D
    Davis, GL
    Wittmers, LE
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2004, 73 (03) : 267 - 278
  • [6] NEUROPEPTIDE-Y DISTRIBUTION IN THE RAT-BRAIN
    ALLEN, YS
    ADRIAN, TE
    ALLEN, JM
    TATEMOTO, K
    CROW, TJ
    BLOOM, SR
    POLAK, JM
    [J]. SCIENCE, 1983, 221 (4613) : 877 - 879
  • [7] Association Between COMT, PTSD, and Increased Smoking Following Hurricane Exposure in an Epidemiologic Sample
    Amstadter, Ananda B.
    Nugent, Nicole R.
    Koenen, Karestan C.
    Ruggiero, Kenneth J.
    Acierno, Ron
    Galea, Sandro
    Kilpatrick, Dean G.
    Gelernter, Joel
    [J]. PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 2009, 72 (04): : 360 - 369
  • [8] DEPRESSION AND THE DYNAMICS OF SMOKING - A NATIONAL PERSPECTIVE
    ANDA, RF
    WILLIAMSON, DF
    ESCOBEDO, LG
    MAST, EE
    GIOVINO, GA
    REMINGTON, PL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (12): : 1541 - 1545
  • [9] INTRAVENOUS INJECTIONS OF NICOTINE INDUCE VERY RAPID AND DISCRETE REDUCTIONS OF HYPOTHALAMIC CATECHOLAMINE LEVELS ASSOCIATED WITH INCREASES OF ACTH, VASOPRESSIN AND PROLACTIN SECRETION
    ANDERSSON, K
    SIEGEL, R
    FUXE, K
    ENEROTH, P
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 118 (01): : 35 - 40
  • [10] Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression
    Andreoli, V
    Caillard, V
    Deo, RS
    Rybakowski, JK
    Versiani, M
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (04) : 393 - 399